Mind over matter - billion-dollar baby: the world of antipsychotics
This article was originally published in Scrip
Executive Summary
The antipsychotic market is huge – the top two products alone account for sales of nearly $10 billion. Yet current products have a number of shortcomings. Here we look at some attempts to address the issues.